Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmbox1
|
ENSMUSG00000021972.8 | homeobox containing 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_64821024_64821175 | Hmbox1 | 1197 | 0.421589 | -0.46 | 4.2e-04 | Click! |
chr14_64817826_64818031 | Hmbox1 | 4368 | 0.180729 | -0.46 | 4.8e-04 | Click! |
chr14_64816226_64816459 | Hmbox1 | 5954 | 0.167033 | -0.43 | 1.2e-03 | Click! |
chr14_64815979_64816130 | Hmbox1 | 6242 | 0.165503 | -0.38 | 3.9e-03 | Click! |
chr14_64818049_64818209 | Hmbox1 | 4167 | 0.183541 | -0.37 | 6.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_84197696_84198961 | 36.70 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr13_100602360_100602562 | 24.36 |
Gm24261 |
predicted gene, 24261 |
1898 |
0.21 |
chr8_81774560_81774750 | 23.56 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
1542 |
0.44 |
chr11_20916554_20916845 | 23.49 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr11_60217619_60217874 | 22.71 |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
2858 |
0.16 |
chr14_75242213_75242389 | 21.62 |
Cpb2 |
carboxypeptidase B2 (plasma) |
14 |
0.97 |
chr13_112745764_112745944 | 21.12 |
Slc38a9 |
solute carrier family 38, member 9 |
10244 |
0.15 |
chr10_128804096_128805293 | 20.12 |
Tmem198b |
transmembrane protein 198b |
324 |
0.61 |
chr13_37460302_37460827 | 19.90 |
Gm29458 |
predicted gene 29458 |
7356 |
0.1 |
chr17_71235414_71235565 | 19.69 |
Lpin2 |
lipin 2 |
3173 |
0.22 |
chr4_130715186_130715488 | 19.38 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34297 |
0.11 |
chr13_32968574_32968873 | 18.35 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
2775 |
0.19 |
chr19_32179842_32180167 | 17.85 |
Sgms1 |
sphingomyelin synthase 1 |
16424 |
0.21 |
chr16_77028015_77028313 | 17.84 |
Usp25 |
ubiquitin specific peptidase 25 |
14377 |
0.21 |
chrX_51204673_51205680 | 17.28 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr6_17680606_17680909 | 17.01 |
St7 |
suppression of tumorigenicity 7 |
12176 |
0.14 |
chr15_79690079_79691459 | 16.70 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr7_103870533_103870999 | 16.59 |
Olfr66 |
olfactory receptor 66 |
11475 |
0.06 |
chr13_24420067_24420235 | 16.52 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2927 |
0.19 |
chr14_12103066_12103217 | 16.51 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
11981 |
0.23 |
chr9_90237307_90237597 | 16.49 |
Gm16200 |
predicted gene 16200 |
15827 |
0.15 |
chr16_90738037_90738648 | 16.41 |
Mrap |
melanocortin 2 receptor accessory protein |
18 |
0.97 |
chr11_117780842_117781082 | 16.19 |
Tmc6 |
transmembrane channel-like gene family 6 |
18 |
0.93 |
chr5_139734130_139734319 | 16.11 |
Micall2 |
MICAL-like 2 |
1390 |
0.34 |
chr10_94020675_94020940 | 16.07 |
Vezt |
vezatin, adherens junctions transmembrane protein |
84 |
0.95 |
chr15_62501001_62501297 | 16.05 |
Gm41333 |
predicted gene, 41333 |
66826 |
0.14 |
chr6_72323826_72324126 | 15.93 |
Usp39 |
ubiquitin specific peptidase 39 |
9392 |
0.11 |
chr7_98330060_98330318 | 15.92 |
Acer3 |
alkaline ceramidase 3 |
8981 |
0.18 |
chr19_32240518_32240679 | 15.90 |
Sgms1 |
sphingomyelin synthase 1 |
1772 |
0.42 |
chr15_83364169_83364529 | 15.89 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
793 |
0.56 |
chr1_88206786_88207160 | 15.81 |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
1191 |
0.22 |
chr6_58648523_58648684 | 15.71 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
8021 |
0.23 |
chr1_33600072_33600973 | 15.28 |
Gm37618 |
predicted gene, 37618 |
16310 |
0.15 |
chr2_69999504_69999656 | 15.17 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
929 |
0.58 |
chr7_66196280_66196431 | 15.11 |
Gm45080 |
predicted gene 45080 |
5800 |
0.17 |
chr7_133702854_133703005 | 15.06 |
Uros |
uroporphyrinogen III synthase |
313 |
0.83 |
chr15_67014626_67015037 | 15.00 |
Gm31342 |
predicted gene, 31342 |
25227 |
0.17 |
chr7_141581345_141581738 | 14.91 |
Ap2a2 |
adaptor-related protein complex 2, alpha 2 subunit |
19011 |
0.1 |
chr13_118630144_118630306 | 14.87 |
Gm10732 |
predicted gene 10732 |
28518 |
0.13 |
chr7_17059591_17061170 | 14.58 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr18_20920762_20920923 | 14.49 |
Rnf125 |
ring finger protein 125 |
23783 |
0.17 |
chr14_57089155_57089477 | 14.42 |
Gjb2 |
gap junction protein, beta 2 |
15386 |
0.14 |
chr15_58926040_58926367 | 14.36 |
Tatdn1 |
TatD DNase domain containing 1 |
7165 |
0.13 |
chr3_153851856_153852016 | 14.33 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
465 |
0.67 |
chr5_103760139_103760316 | 14.30 |
Aff1 |
AF4/FMR2 family, member 1 |
5654 |
0.23 |
chr11_98580301_98580503 | 13.94 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6966 |
0.11 |
chr1_140415769_140416105 | 13.93 |
Kcnt2 |
potassium channel, subfamily T, member 2 |
26999 |
0.25 |
chr4_42879962_42880119 | 13.91 |
Fam205c |
family with sequence similarity 205, member C |
5806 |
0.14 |
chr7_103877549_103877803 | 13.83 |
Olfr66 |
olfactory receptor 66 |
4565 |
0.07 |
chr2_158305932_158306715 | 13.81 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chr8_67569204_67569504 | 13.75 |
Gm36247 |
predicted gene, 36247 |
15836 |
0.18 |
chr5_123035197_123035354 | 13.71 |
Gm43412 |
predicted gene 43412 |
725 |
0.44 |
chr6_58643041_58643202 | 13.66 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2539 |
0.33 |
chr11_49089383_49089543 | 13.65 |
Gm12188 |
predicted gene 12188 |
920 |
0.3 |
chr7_110774760_110775022 | 13.63 |
Ampd3 |
adenosine monophosphate deaminase 3 |
647 |
0.63 |
chr6_72097140_72098281 | 13.60 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr4_49451596_49451772 | 13.56 |
Acnat1 |
acyl-coenzyme A amino acid N-acyltransferase 1 |
547 |
0.69 |
chr15_100411166_100411351 | 13.42 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
7836 |
0.11 |
chr14_31260375_31260754 | 13.17 |
Bap1 |
Brca1 associated protein 1 |
3073 |
0.14 |
chr5_22557624_22557806 | 12.92 |
6030443J06Rik |
RIKEN cDNA 6030443J06 gene |
3800 |
0.14 |
chr1_153770335_153770651 | 12.92 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
14509 |
0.1 |
chr11_78982143_78982376 | 12.91 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2572 |
0.27 |
chr13_93234781_93234932 | 12.89 |
Tent2 |
terminal nucleotidyltransferase 2 |
42471 |
0.12 |
chr1_134526691_134526981 | 12.88 |
Gm29376 |
predicted gene 29376 |
6858 |
0.11 |
chr13_3893752_3894420 | 12.86 |
Net1 |
neuroepithelial cell transforming gene 1 |
508 |
0.69 |
chr16_35807108_35807273 | 12.77 |
Gm26838 |
predicted gene, 26838 |
1756 |
0.26 |
chr10_98906099_98906275 | 12.67 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
8219 |
0.28 |
chr1_77298255_77298528 | 12.64 |
Epha4 |
Eph receptor A4 |
79216 |
0.11 |
chr9_50811130_50811331 | 12.61 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2551 |
0.2 |
chr19_16435353_16436213 | 12.44 |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
21 |
0.98 |
chr6_138424907_138425582 | 12.42 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr1_91301323_91301486 | 12.40 |
Scly |
selenocysteine lyase |
1393 |
0.28 |
chr9_111126875_111127035 | 12.40 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
7280 |
0.16 |
chr6_135166144_135166455 | 12.35 |
Hebp1 |
heme binding protein 1 |
1836 |
0.21 |
chr14_12105160_12105311 | 12.33 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
14075 |
0.22 |
chr4_117135895_117136088 | 12.33 |
Plk3 |
polo like kinase 3 |
2028 |
0.11 |
chr1_64733560_64733723 | 12.27 |
Gm38058 |
predicted gene, 38058 |
2599 |
0.22 |
chr13_91474145_91474307 | 12.27 |
Ssbp2 |
single-stranded DNA binding protein 2 |
13045 |
0.25 |
chr5_146250723_146251020 | 12.22 |
Gm15739 |
predicted gene 15739 |
2320 |
0.2 |
chr18_36665775_36666181 | 12.21 |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
1918 |
0.16 |
chr1_88492035_88492194 | 12.20 |
Glrp1 |
glutamine repeat protein 1 |
17952 |
0.14 |
chr9_45788631_45788801 | 12.18 |
Cep164 |
centrosomal protein 164 |
5550 |
0.14 |
chr2_152816257_152816836 | 12.18 |
Bcl2l1 |
BCL2-like 1 |
11989 |
0.12 |
chr17_84262332_84262700 | 12.17 |
Gm24492 |
predicted gene, 24492 |
25231 |
0.16 |
chr9_108341843_108342144 | 12.14 |
Gpx1 |
glutathione peroxidase 1 |
2717 |
0.1 |
chr7_100860494_100860825 | 12.12 |
Relt |
RELT tumor necrosis factor receptor |
2499 |
0.21 |
chr3_28736995_28737357 | 12.12 |
1700112D23Rik |
RIKEN cDNA 1700112D23 gene |
5064 |
0.16 |
chr5_29963573_29963740 | 12.08 |
Gm43386 |
predicted gene 43386 |
12938 |
0.16 |
chr11_62605415_62606716 | 12.08 |
Lrrc75aos2 |
leucine rich repeat containing 75A, opposite strand 2 |
298 |
0.72 |
chr14_79506052_79506246 | 12.06 |
Elf1 |
E74-like factor 1 |
9525 |
0.16 |
chr11_86663604_86663872 | 12.05 |
Vmp1 |
vacuole membrane protein 1 |
165 |
0.94 |
chr13_23683510_23684675 | 12.03 |
H2bc4 |
H2B clustered histone 4 |
107 |
0.49 |
chr1_167392688_167392913 | 12.02 |
Mgst3 |
microsomal glutathione S-transferase 3 |
1041 |
0.48 |
chr5_103738192_103738402 | 12.00 |
Aff1 |
AF4/FMR2 family, member 1 |
15865 |
0.19 |
chrX_150564718_150565009 | 11.86 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
1527 |
0.32 |
chr8_35567247_35567548 | 11.86 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
20401 |
0.17 |
chr5_37457926_37458192 | 11.84 |
Evc2 |
EvC ciliary complex subunit 2 |
42200 |
0.16 |
chr13_73475128_73475301 | 11.76 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
3463 |
0.27 |
chr5_86906866_86907068 | 11.75 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
30 |
0.96 |
chr11_69062573_69063351 | 11.75 |
9330160F10Rik |
RIKEN cDNA 9330160F10 gene |
2479 |
0.1 |
chr4_46404626_46404791 | 11.71 |
Hemgn |
hemogen |
472 |
0.73 |
chrX_7970964_7971256 | 11.71 |
Gata1 |
GATA binding protein 1 |
3200 |
0.11 |
chr11_62159887_62160160 | 11.69 |
AL592080.1 |
sperm antigen with calponin homology and coiled-coil domains 1 (Specc1) pseudogene |
42604 |
0.13 |
chr8_85380323_85380758 | 11.69 |
Mylk3 |
myosin light chain kinase 3 |
438 |
0.77 |
chr19_32239753_32239908 | 11.68 |
Sgms1 |
sphingomyelin synthase 1 |
1004 |
0.61 |
chr11_32298735_32298903 | 11.67 |
Hbq1a |
hemoglobin, theta 1A |
1250 |
0.28 |
chr14_63124182_63124356 | 11.66 |
Ctsb |
cathepsin B |
1755 |
0.27 |
chr3_19634737_19635180 | 11.66 |
1700064H15Rik |
RIKEN cDNA 1700064H15 gene |
6281 |
0.16 |
chr1_195091756_195092192 | 11.66 |
Cd46 |
CD46 antigen, complement regulatory protein |
251 |
0.87 |
chr10_40077698_40077860 | 11.65 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1174 |
0.41 |
chr10_84639605_84639777 | 11.62 |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
595 |
0.69 |
chr19_28929181_28929351 | 11.39 |
4430402I18Rik |
RIKEN cDNA 4430402I18 gene |
39 |
0.97 |
chr17_28828817_28829152 | 11.36 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
902 |
0.41 |
chr17_24427147_24427444 | 11.25 |
Eci1 |
enoyl-Coenzyme A delta isomerase 1 |
304 |
0.75 |
chr3_84383754_84384080 | 11.24 |
4930565D16Rik |
RIKEN cDNA 4930565D16 gene |
3996 |
0.29 |
chr18_25097355_25097753 | 11.12 |
Fhod3 |
formin homology 2 domain containing 3 |
26807 |
0.22 |
chr14_32165245_32165569 | 11.12 |
Ncoa4 |
nuclear receptor coactivator 4 |
182 |
0.9 |
chr2_91643187_91643369 | 11.11 |
Gm13771 |
predicted gene 13771 |
1356 |
0.28 |
chr19_37561646_37561845 | 11.09 |
Exoc6 |
exocyst complex component 6 |
11286 |
0.21 |
chr1_131638611_131638779 | 11.07 |
Ctse |
cathepsin E |
201 |
0.93 |
chr11_4553398_4553552 | 11.07 |
Mtmr3 |
myotubularin related protein 3 |
7207 |
0.17 |
chr3_127792203_127792376 | 11.04 |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
1485 |
0.27 |
chr14_63124372_63124586 | 10.98 |
Ctsb |
cathepsin B |
1965 |
0.24 |
chr13_11836757_11837070 | 10.95 |
Ryr2 |
ryanodine receptor 2, cardiac |
7259 |
0.24 |
chr5_140615331_140615546 | 10.94 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
3753 |
0.16 |
chr4_118079198_118079529 | 10.93 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
47481 |
0.11 |
chr13_23535149_23535834 | 10.93 |
H3c8 |
H3 clustered histone 8 |
69 |
0.86 |
chr15_103250587_103250875 | 10.92 |
Nfe2 |
nuclear factor, erythroid derived 2 |
734 |
0.49 |
chr1_72237084_72237400 | 10.84 |
Gm23472 |
predicted gene, 23472 |
296 |
0.84 |
chrX_9256889_9257156 | 10.80 |
Gm14862 |
predicted gene 14862 |
123 |
0.95 |
chr9_50594626_50595065 | 10.79 |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
8967 |
0.1 |
chr4_154881520_154881680 | 10.75 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
609 |
0.63 |
chr6_29695948_29696300 | 10.75 |
Tspan33 |
tetraspanin 33 |
1890 |
0.32 |
chr2_167431166_167431353 | 10.74 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7140 |
0.18 |
chr9_64793074_64793409 | 10.73 |
Dennd4a |
DENN/MADD domain containing 4A |
18099 |
0.18 |
chr5_5186166_5186392 | 10.71 |
Cdk14 |
cyclin-dependent kinase 14 |
9076 |
0.17 |
chr8_33987076_33987405 | 10.70 |
Gm45817 |
predicted gene 45817 |
40 |
0.96 |
chr6_80555113_80555264 | 10.68 |
Gm44242 |
predicted gene, 44242 |
40594 |
0.19 |
chr8_5030765_5030932 | 10.66 |
n-R5s93 |
nuclear encoded rRNA 5S 93 |
38529 |
0.14 |
chr4_59247588_59247854 | 10.66 |
Gm12596 |
predicted gene 12596 |
12330 |
0.18 |
chr9_31302051_31302208 | 10.66 |
Prdm10 |
PR domain containing 10 |
11424 |
0.16 |
chr1_82825306_82825469 | 10.65 |
Gm17764 |
predicted gene, 17764 |
2526 |
0.14 |
chr6_149278562_149278728 | 10.63 |
Gm10388 |
predicted gene 10388 |
8128 |
0.16 |
chr2_132846257_132847404 | 10.62 |
Crls1 |
cardiolipin synthase 1 |
142 |
0.79 |
chr3_59063502_59063682 | 10.62 |
Gpr171 |
G protein-coupled receptor 171 |
38229 |
0.11 |
chr1_191846706_191847003 | 10.61 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
19706 |
0.13 |
chr18_34516209_34516494 | 10.61 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
6614 |
0.15 |
chr11_32250921_32251298 | 10.53 |
Nprl3 |
nitrogen permease regulator-like 3 |
831 |
0.45 |
chr15_16311782_16311933 | 10.52 |
Gm6479 |
predicted gene 6479 |
103904 |
0.08 |
chr3_100438511_100438708 | 10.52 |
Gm43121 |
predicted gene 43121 |
775 |
0.58 |
chr1_88013855_88014022 | 10.47 |
Gm25198 |
predicted gene, 25198 |
1986 |
0.16 |
chr4_132072343_132072494 | 10.44 |
Epb41 |
erythrocyte membrane protein band 4.1 |
321 |
0.8 |
chrX_109137317_109137575 | 10.42 |
Gm14869 |
predicted gene 14869 |
15762 |
0.19 |
chr2_119155084_119155280 | 10.37 |
Rmdn3 |
regulator of microtubule dynamics 3 |
1642 |
0.23 |
chr6_127322417_127322756 | 10.34 |
Gm42458 |
predicted gene 42458 |
3271 |
0.16 |
chr13_17028260_17028429 | 10.32 |
Gm27043 |
predicted gene, 27043 |
22577 |
0.23 |
chr14_75139163_75139334 | 10.32 |
Gm15628 |
predicted gene 15628 |
2336 |
0.23 |
chr2_93452559_93452818 | 10.29 |
Cd82 |
CD82 antigen |
5 |
0.63 |
chr9_95854958_95855179 | 10.29 |
1700065D16Rik |
RIKEN cDNA 1700065D16 gene |
2449 |
0.21 |
chr9_114817367_114817518 | 10.23 |
Gm23889 |
predicted gene, 23889 |
20731 |
0.14 |
chr19_3834443_3834636 | 10.21 |
Gm19209 |
predicted gene, 19209 |
12150 |
0.09 |
chr16_11614396_11614547 | 10.21 |
Gm4279 |
predicted gene 4279 |
77386 |
0.1 |
chr2_35336161_35336328 | 10.16 |
Stom |
stomatin |
732 |
0.57 |
chr9_7790636_7790802 | 10.12 |
Mir5618 |
microRNA 5618 |
6329 |
0.15 |
chr8_86759318_86759496 | 10.11 |
Siah1a |
siah E3 ubiquitin protein ligase 1A |
13473 |
0.17 |
chr8_94179443_94179635 | 10.11 |
Mt1 |
metallothionein 1 |
298 |
0.8 |
chr10_83945524_83945740 | 10.09 |
Gm47247 |
predicted gene, 47247 |
43780 |
0.15 |
chr2_71146233_71146533 | 10.06 |
Cybrd1 |
cytochrome b reductase 1 |
28460 |
0.18 |
chr16_49799705_49799872 | 10.06 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
745 |
0.51 |
chr14_79530269_79530420 | 10.05 |
Elf1 |
E74-like factor 1 |
14646 |
0.15 |
chr11_87367979_87368147 | 10.04 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9040 |
0.12 |
chr13_67080945_67081420 | 10.03 |
Zfp708 |
zinc finger protein 708 |
330 |
0.75 |
chr5_148978219_148978756 | 10.02 |
Gm42791 |
predicted gene 42791 |
2606 |
0.13 |
chr11_31835746_31836021 | 10.00 |
Gm12107 |
predicted gene 12107 |
3223 |
0.25 |
chr12_57186160_57186531 | 9.97 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
11127 |
0.21 |
chr9_21030784_21032385 | 9.96 |
Icam5 |
intercellular adhesion molecule 5, telencephalin |
489 |
0.37 |
chr1_171502834_171503019 | 9.93 |
Gm24871 |
predicted gene, 24871 |
237 |
0.68 |
chr15_58927331_58927482 | 9.93 |
Tatdn1 |
TatD DNase domain containing 1 |
5962 |
0.13 |
chr1_182268291_182268667 | 9.89 |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
13745 |
0.17 |
chr10_127138481_127138637 | 9.88 |
Gm23664 |
predicted gene, 23664 |
58 |
0.93 |
chr3_88501277_88501459 | 9.86 |
Lmna |
lamin A |
1939 |
0.15 |
chr12_27666610_27666780 | 9.86 |
Gm24326 |
predicted gene, 24326 |
34892 |
0.21 |
chr2_115912007_115912210 | 9.85 |
Meis2 |
Meis homeobox 2 |
39146 |
0.21 |
chr8_40572970_40573513 | 9.84 |
Mtmr7 |
myotubularin related protein 7 |
17273 |
0.16 |
chr3_89136366_89136871 | 9.83 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr5_143625595_143625787 | 9.81 |
Cyth3 |
cytohesin 3 |
3157 |
0.24 |
chr15_62043036_62043227 | 9.80 |
Pvt1 |
Pvt1 oncogene |
3874 |
0.3 |
chr12_105019976_105020259 | 9.79 |
Gm47648 |
predicted gene, 47648 |
1242 |
0.29 |
chr13_23533504_23534327 | 9.77 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr5_75358882_75359196 | 9.76 |
Gm22084 |
predicted gene, 22084 |
13106 |
0.18 |
chr8_18950188_18951286 | 9.76 |
Xkr5 |
X-linked Kx blood group related 5 |
134 |
0.94 |
chr11_116536788_116536976 | 9.75 |
Sphk1 |
sphingosine kinase 1 |
2142 |
0.16 |
chr16_96918984_96919312 | 9.74 |
Gm32432 |
predicted gene, 32432 |
391 |
0.92 |
chr7_80049865_80050016 | 9.74 |
Gm44951 |
predicted gene 44951 |
13235 |
0.11 |
chr19_34844974_34845148 | 9.73 |
Mir107 |
microRNA 107 |
24288 |
0.12 |
chr9_78533358_78533557 | 9.72 |
Gm47430 |
predicted gene, 47430 |
12911 |
0.13 |
chr4_45851795_45851998 | 9.72 |
Stra6l |
STRA6-like |
2899 |
0.22 |
chr19_4060684_4060835 | 9.71 |
Gstp3 |
glutathione S-transferase pi 3 |
1190 |
0.21 |
chr2_164774335_164774528 | 9.69 |
Ube2c |
ubiquitin-conjugating enzyme E2C |
4528 |
0.08 |
chr5_113164821_113165497 | 9.64 |
Gm43094 |
predicted gene 43094 |
1075 |
0.34 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 24.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
6.8 | 34.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
5.0 | 19.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.7 | 14.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.3 | 17.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
4.2 | 16.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
4.2 | 16.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
4.1 | 12.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
4.0 | 15.8 | GO:0046618 | drug export(GO:0046618) |
3.9 | 11.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
3.8 | 3.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.7 | 11.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.7 | 11.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.6 | 14.4 | GO:0034214 | protein hexamerization(GO:0034214) |
3.4 | 10.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.4 | 10.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
3.2 | 3.2 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
3.1 | 15.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.1 | 12.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.1 | 9.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
3.0 | 12.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.9 | 8.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.9 | 11.8 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.9 | 8.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.9 | 11.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.9 | 8.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.9 | 5.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.8 | 14.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.8 | 16.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.8 | 8.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.8 | 11.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.7 | 8.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.7 | 8.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
2.7 | 8.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.7 | 10.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.6 | 15.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.6 | 2.6 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.6 | 7.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.5 | 15.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
2.5 | 19.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.5 | 49.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.5 | 9.8 | GO:0008228 | opsonization(GO:0008228) |
2.4 | 9.8 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
2.4 | 7.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
2.4 | 9.8 | GO:0032264 | IMP salvage(GO:0032264) |
2.4 | 7.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.3 | 4.7 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.3 | 2.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.3 | 16.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
2.2 | 9.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.2 | 6.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.2 | 8.9 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
2.2 | 6.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.2 | 8.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
2.2 | 6.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.2 | 6.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.2 | 6.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.2 | 19.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.1 | 6.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.1 | 12.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.1 | 6.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.1 | 6.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.1 | 8.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.1 | 4.2 | GO:0061511 | centriole elongation(GO:0061511) |
2.1 | 10.4 | GO:1904970 | brush border assembly(GO:1904970) |
2.0 | 14.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
2.0 | 10.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.0 | 10.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
2.0 | 4.0 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.0 | 6.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.0 | 6.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.0 | 6.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.0 | 4.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.0 | 9.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.0 | 7.8 | GO:0003383 | apical constriction(GO:0003383) |
1.9 | 5.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.9 | 9.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.8 | 7.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.8 | 7.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.8 | 7.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.8 | 14.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.8 | 10.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.8 | 5.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.8 | 10.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 9.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.8 | 5.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.8 | 7.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.8 | 8.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.8 | 5.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.8 | 1.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.7 | 10.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.7 | 3.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.7 | 5.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.7 | 6.8 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.7 | 10.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.7 | 5.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.7 | 13.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.7 | 5.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.7 | 6.8 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.7 | 13.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.7 | 5.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.7 | 11.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.7 | 5.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.7 | 5.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.7 | 6.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.7 | 6.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.7 | 5.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.7 | 5.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.7 | 6.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
1.7 | 5.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.7 | 6.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.7 | 3.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.6 | 3.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.6 | 8.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.6 | 1.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.6 | 4.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.6 | 8.1 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.6 | 4.8 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.6 | 4.8 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
1.6 | 6.3 | GO:0009597 | detection of virus(GO:0009597) |
1.6 | 3.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.6 | 4.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.6 | 1.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.6 | 3.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.5 | 4.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.5 | 9.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.5 | 4.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.5 | 6.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.5 | 7.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.5 | 1.5 | GO:0051231 | spindle elongation(GO:0051231) |
1.5 | 10.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.5 | 5.9 | GO:0019695 | choline metabolic process(GO:0019695) |
1.5 | 4.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.5 | 4.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.5 | 5.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.5 | 4.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.5 | 2.9 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.4 | 5.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.4 | 5.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.4 | 25.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.4 | 2.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
1.4 | 8.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.4 | 5.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 7.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.4 | 1.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.4 | 12.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 8.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.4 | 5.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.4 | 4.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.4 | 2.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.4 | 4.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.4 | 10.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.4 | 5.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.3 | 4.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.3 | 10.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.3 | 4.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.3 | 1.3 | GO:0007127 | meiosis I(GO:0007127) |
1.3 | 6.6 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 3.9 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.3 | 3.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.3 | 5.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.3 | 1.3 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 1.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.3 | 26.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.3 | 2.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.3 | 3.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.3 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.3 | 5.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.3 | 5.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.3 | 3.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.3 | 5.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.3 | 7.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.3 | 10.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.2 | 3.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.2 | 3.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.2 | 6.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.2 | 3.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.2 | 3.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.2 | 1.2 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.2 | 3.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.2 | 4.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.2 | 2.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.2 | 3.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.2 | 3.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.2 | 1.2 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
1.2 | 4.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 2.4 | GO:0006573 | valine metabolic process(GO:0006573) |
1.2 | 13.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
1.2 | 2.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.2 | 17.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.2 | 22.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
1.2 | 7.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 7.1 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 8.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.2 | 4.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.2 | 7.0 | GO:0016266 | O-glycan processing(GO:0016266) |
1.2 | 3.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.2 | 2.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 2.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.2 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.2 | 18.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.2 | 2.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.1 | 25.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.1 | 1.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.1 | 3.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.1 | 6.9 | GO:0001705 | ectoderm formation(GO:0001705) |
1.1 | 1.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.1 | 3.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.1 | 3.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.1 | 2.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.1 | 3.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.1 | 2.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.1 | 2.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 4.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.1 | 3.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.1 | 7.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 3.3 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 3.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.1 | 2.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.1 | 5.5 | GO:0042737 | drug catabolic process(GO:0042737) |
1.1 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.1 | 1.1 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.1 | 3.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 1.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.1 | 4.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.1 | 1.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.1 | 2.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.1 | 10.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.1 | 9.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.0 | 5.2 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.0 | 6.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.0 | 5.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.0 | 4.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.0 | 9.3 | GO:0070269 | pyroptosis(GO:0070269) |
1.0 | 7.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.0 | 2.1 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.0 | 3.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.0 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.0 | 2.0 | GO:1902896 | terminal web assembly(GO:1902896) |
1.0 | 3.1 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
1.0 | 4.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 3.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.0 | 3.0 | GO:0001757 | somite specification(GO:0001757) |
1.0 | 6.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.0 | 4.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.0 | 4.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 4.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.0 | 12.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.0 | 3.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.0 | 26.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.0 | 1.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 9.9 | GO:0050779 | RNA destabilization(GO:0050779) |
1.0 | 5.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 5.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.0 | 7.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.0 | 1.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.0 | 9.9 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.0 | 3.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.0 | 5.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.0 | 2.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 6.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.0 | 2.9 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 1.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.0 | 1.0 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
1.0 | 8.8 | GO:0051451 | myoblast migration(GO:0051451) |
1.0 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.0 | 3.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.0 | 2.9 | GO:0000050 | urea cycle(GO:0000050) |
1.0 | 1.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.0 | 2.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.0 | 8.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 5.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.0 | 1.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.0 | 1.0 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.0 | 5.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.0 | 2.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 2.9 | GO:0051593 | response to folic acid(GO:0051593) |
1.0 | 6.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.0 | 1.0 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 14.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 2.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.9 | 14.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.9 | 2.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 12.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.9 | 8.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 2.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.9 | 11.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.9 | 3.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.9 | 10.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.9 | 1.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.9 | 0.9 | GO:0061724 | lipophagy(GO:0061724) |
0.9 | 7.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.9 | 1.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 2.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 6.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.9 | 4.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.9 | 2.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 6.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.9 | 17.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.9 | 5.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.9 | 1.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.9 | 2.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 2.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.9 | 1.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 3.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.9 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.9 | 0.9 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.9 | 2.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.9 | 1.8 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.9 | 2.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 3.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.9 | 3.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.9 | 0.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.9 | 4.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 0.9 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.9 | 8.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.9 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 14.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.9 | 3.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.9 | 0.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.9 | 6.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.9 | 7.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 1.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.9 | 3.5 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.9 | 6.9 | GO:0046697 | decidualization(GO:0046697) |
0.9 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.9 | 3.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.9 | 1.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 2.6 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.9 | 2.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.9 | 2.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.9 | 27.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.9 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.9 | 1.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 1.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.9 | 2.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.9 | 0.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.8 | 1.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 1.7 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.8 | 3.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 1.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.8 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 1.7 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.8 | 1.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.8 | 4.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 1.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.8 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.8 | 1.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.8 | 5.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.8 | 3.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.8 | 4.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 4.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.8 | 0.8 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.8 | 1.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.8 | 2.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.8 | 0.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.8 | 3.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.8 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.8 | 14.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 2.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.8 | 3.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.8 | 6.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.8 | 2.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.8 | 4.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.8 | 0.8 | GO:0072526 | pyridine nucleotide catabolic process(GO:0019364) pyridine-containing compound catabolic process(GO:0072526) |
0.8 | 5.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.8 | 2.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.8 | 2.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 3.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.8 | 2.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 0.8 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.8 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.8 | 6.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 3.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.8 | 11.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.8 | 2.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 3.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 6.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 1.6 | GO:0032898 | neurotrophin production(GO:0032898) |
0.8 | 9.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.8 | 9.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.8 | 1.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.8 | 5.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.8 | 5.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.8 | 2.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.8 | 0.8 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.8 | 0.8 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.8 | 2.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 1.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.8 | 2.3 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.8 | 0.8 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.8 | 3.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.8 | 3.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.8 | 0.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 3.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.8 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.8 | 0.8 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.8 | 0.8 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 2.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.8 | 4.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.8 | 3.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.8 | 2.3 | GO:0019042 | viral latency(GO:0019042) |
0.8 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.8 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.8 | 0.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.7 | 6.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.7 | 3.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.7 | 0.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 3.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 2.2 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.7 | 0.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 2.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 2.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.7 | 4.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.7 | 1.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 2.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.7 | 5.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.7 | 1.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.7 | 5.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.7 | 1.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 2.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 0.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.7 | 1.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.7 | 3.6 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 1.4 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.7 | 2.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 3.6 | GO:0036233 | glycine import(GO:0036233) |
0.7 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 2.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 5.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 1.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 2.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.7 | 0.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.7 | 4.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.7 | 2.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.7 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 0.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 0.7 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.7 | 4.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 2.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 1.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.7 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.7 | 4.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 2.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 3.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.7 | 13.8 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.7 | 2.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.7 | 2.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.7 | 4.8 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.7 | 2.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.7 | 2.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 7.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.7 | 4.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 2.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.7 | 2.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 4.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.7 | 3.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.7 | 1.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.7 | 2.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 2.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 4.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.7 | 2.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.7 | 2.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.7 | 6.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.7 | 10.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.7 | 5.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.7 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 4.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 5.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.7 | 0.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.7 | 1.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.7 | 11.3 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.7 | 3.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.7 | 2.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 4.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 4.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 2.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 6.6 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.7 | 2.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.7 | 4.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.7 | 9.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.7 | 3.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 3.9 | GO:0070254 | mucus secretion(GO:0070254) |
0.6 | 1.9 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.6 | 1.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 16.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 3.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.6 | 1.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.6 | 1.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 1.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.3 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.6 | 3.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 0.6 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.6 | 13.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 12.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.6 | 3.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 1.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.6 | 1.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.6 | 3.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 0.6 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.6 | 2.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.6 | 5.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.6 | 1.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 3.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 1.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 3.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.6 | 1.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 4.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.6 | 1.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 0.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.6 | 6.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.6 | 1.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.6 | 1.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 3.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 1.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 4.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.6 | 2.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.6 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 3.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 4.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.6 | 4.7 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 3.5 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.6 | 3.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.6 | 7.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 12.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.6 | 1.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 2.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.6 | 8.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.6 | 3.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 0.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.6 | 2.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.6 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 1.7 | GO:1901727 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 1.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.6 | 2.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 6.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.6 | 4.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.6 | 1.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 4.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 1.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 5.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 1.7 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 2.8 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.6 | 3.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.6 | 1.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 3.4 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.6 | 0.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 0.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.6 | 7.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 1.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.6 | 0.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.6 | 7.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.6 | 1.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 0.6 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.6 | 1.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.6 | 7.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.6 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 2.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 3.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 5.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.6 | 12.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.6 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 4.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.6 | 1.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.6 | 0.6 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.6 | 2.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 7.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.5 | 3.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 0.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.5 | 1.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 1.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 1.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 2.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.5 | 2.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 2.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 2.7 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.5 | 4.9 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.5 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 0.5 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.5 | 2.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 4.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 4.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.5 | 5.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 3.2 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.5 | 1.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 3.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.5 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 3.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 1.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.5 | 2.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 3.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 0.5 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.5 | 1.0 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.5 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 7.8 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 1.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 1.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 2.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 3.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 1.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 0.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.5 | 1.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 7.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 3.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 4.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.5 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 0.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 1.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.5 | 2.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 9.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 2.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 1.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 1.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 2.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 4.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 1.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 2.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 1.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 9.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.5 | 1.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.5 | 1.0 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.5 | 17.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.5 | 3.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 5.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 8.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.5 | 13.2 | GO:1901998 | toxin transport(GO:1901998) |
0.5 | 3.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.5 | 1.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 1.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.9 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.5 | 7.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.5 | 3.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.5 | 1.5 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 1.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.5 | 2.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 5.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.5 | 0.5 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 17.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 1.0 | GO:0006833 | water transport(GO:0006833) |
0.5 | 2.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 3.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 2.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 2.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 18.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 1.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.5 | 4.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 5.7 | GO:0051591 | response to cAMP(GO:0051591) |
0.5 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 5.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 0.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 2.3 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.5 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.5 | 0.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.5 | 2.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 6.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.5 | 3.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 8.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 0.9 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.5 | 6.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 0.5 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.5 | 1.8 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.5 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 0.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.5 | 4.5 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.5 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.5 | 4.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 0.5 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.5 | 2.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 0.9 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 3.6 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.4 | 0.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.4 | 2.7 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.4 | 3.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 3.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 2.2 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 7.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 3.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 2.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 0.4 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.4 | 5.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 1.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 12.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 1.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 1.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 0.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.9 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.4 | 3.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 1.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 9.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.4 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 0.4 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.4 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 2.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 2.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 0.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 1.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 2.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 2.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 3.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 3.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 2.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 0.4 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.4 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 2.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 18.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.4 | 14.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.4 | 2.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 0.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 2.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 1.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.4 | 0.8 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 2.0 | GO:0051180 | vitamin transport(GO:0051180) |
0.4 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 0.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 2.4 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.4 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 4.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 0.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.4 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 1.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 4.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 0.8 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 1.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 4.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 2.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 3.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 0.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 2.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 3.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.4 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.4 | 1.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 6.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 2.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 1.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.8 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.4 | 13.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.4 | 9.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 0.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.4 | 0.8 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.4 | 1.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 0.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.4 | 1.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 1.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 0.4 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 1.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 2.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.4 | 1.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 1.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 0.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 0.4 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.4 | 3.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.4 | 0.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 3.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.4 | 1.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 0.7 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 1.5 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.4 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 0.7 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 26.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 0.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 0.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 1.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 1.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 2.9 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.4 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 1.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 7.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 4.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 1.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 2.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 0.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 2.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 0.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 11.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 4.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.3 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 3.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 1.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.0 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 1.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 2.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 5.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 0.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.3 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 1.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 1.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 1.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 4.0 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.3 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 7.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 8.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 1.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 1.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 11.5 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 23.2 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 3.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.6 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.3 | 1.0 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 1.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.3 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 1.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 1.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 1.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 5.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 3.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 1.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.3 | 0.6 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 5.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 3.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 2.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.9 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 0.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 1.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.3 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 0.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 0.3 | GO:0009452 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.3 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) |
0.3 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.3 | 0.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 5.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 1.2 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.3 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 2.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 1.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.6 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.3 | 1.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 1.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 0.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.3 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 0.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 0.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 8.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 3.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 5.7 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 5.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 3.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 3.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 1.1 | GO:0045141 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 2.0 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.3 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 0.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.3 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 1.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 3.0 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 3.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 5.5 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 0.6 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.3 | 3.0 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.3 | 2.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 4.9 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 2.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.3 | 0.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 0.8 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 2.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 2.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 2.7 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.6 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.3 | 0.5 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 0.3 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 1.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 2.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 5.7 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 1.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 2.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 1.5 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.3 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.3 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.3 | 2.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 1.5 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.3 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 9.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 0.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.5 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.2 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.2 | 0.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 1.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 2.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 2.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.7 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 8.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.9 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.2 | 2.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 1.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 3.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 1.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.9 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 1.4 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 18.9 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 15.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.7 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 2.3 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 3.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 9.7 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.2 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 2.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.9 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 5.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 25.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.2 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.2 | 0.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 1.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 2.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 1.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.2 | 0.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 1.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 10.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 7.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.2 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 2.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.6 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.2 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 4.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 4.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.0 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.2 | 1.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 3.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 4.6 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.2 | 0.9 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.2 | 3.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 5.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.2 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 1.3 | GO:0032094 | response to food(GO:0032094) |
0.2 | 1.5 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 5.5 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.2 | 1.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 2.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.9 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.2 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 2.4 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 4.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 4.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 1.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 0.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.2 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.2 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 2.8 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 5.2 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.2 | 6.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.5 | GO:1901317 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.2 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 0.3 | GO:0034405 | response to fluid shear stress(GO:0034405) cellular response to fluid shear stress(GO:0071498) |
0.2 | 0.2 | GO:0090656 | t-circle formation(GO:0090656) regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.3 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 0.3 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.5 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.2 | 6.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.2 | 0.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 3.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.9 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.2 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.5 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 2.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 1.9 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 1.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 1.7 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 4.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.8 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 2.7 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.1 | 0.1 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 3.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 4.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.5 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 3.8 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 26.8 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 2.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 1.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 1.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 2.7 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 6.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.4 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 0.1 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.3 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.1 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.1 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 4.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 2.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.9 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 2.3 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 1.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.3 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.2 | GO:0045924 | regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.9 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0045913 | positive regulation of carbohydrate metabolic process(GO:0045913) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 1.8 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 1.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.3 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 6.2 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 7.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.1 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.7 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.2 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.1 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) T-helper cell differentiation(GO:0042093) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.7 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 1.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.5 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 0.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.0 | 0.0 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 2.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.3 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.6 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.0 | 31.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.7 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.0 | 0.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 1.1 | GO:0071222 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.4 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 6.1 | GO:0089701 | U2AF(GO:0089701) |
5.5 | 16.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
5.1 | 20.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
5.0 | 30.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.0 | 11.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
2.8 | 8.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.8 | 2.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
2.7 | 13.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.7 | 8.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.6 | 10.5 | GO:1990130 | Iml1 complex(GO:1990130) |
2.5 | 17.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.1 | 8.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.9 | 7.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.9 | 7.5 | GO:0098536 | deuterosome(GO:0098536) |
1.8 | 8.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.7 | 5.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.7 | 17.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.7 | 1.7 | GO:0000811 | GINS complex(GO:0000811) |
1.6 | 4.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.6 | 1.6 | GO:0016939 | kinesin II complex(GO:0016939) |
1.6 | 4.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.6 | 1.6 | GO:0033269 | internode region of axon(GO:0033269) |
1.6 | 7.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.5 | 15.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.4 | 10.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.4 | 21.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.4 | 5.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.4 | 10.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.4 | 22.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.4 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
1.4 | 2.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.4 | 8.1 | GO:0070820 | tertiary granule(GO:0070820) |
1.3 | 4.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.3 | 6.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.3 | 3.9 | GO:0032587 | ruffle membrane(GO:0032587) |
1.3 | 7.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.2 | 13.5 | GO:0070938 | contractile ring(GO:0070938) |
1.2 | 2.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.2 | 3.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.2 | 2.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.2 | 3.5 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 5.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.1 | 2.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.1 | 12.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 3.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 3.3 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 5.4 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 3.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.1 | 10.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
1.1 | 1.1 | GO:1903349 | omegasome membrane(GO:1903349) |
1.0 | 6.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 14.7 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 7.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 6.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 7.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.0 | 5.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.0 | 8.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.0 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 11.0 | GO:0032797 | SMN complex(GO:0032797) |
1.0 | 3.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 2.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 2.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 2.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.0 | 12.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.0 | 10.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 5.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.9 | 5.6 | GO:0005818 | aster(GO:0005818) |
0.9 | 3.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 3.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.9 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.9 | 2.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 4.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.9 | 4.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 5.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 4.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 5.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 2.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.9 | 1.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.9 | 3.4 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 3.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 11.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 0.8 | GO:0030120 | vesicle coat(GO:0030120) |
0.8 | 2.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.8 | 2.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 3.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.8 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 14.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.8 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.8 | 3.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 5.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 8.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.8 | 2.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.8 | 6.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.8 | 3.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.8 | 2.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.8 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 26.7 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 3.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.7 | 5.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 3.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.7 | 11.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 2.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 0.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.7 | 21.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 4.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.7 | 5.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.7 | 8.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 34.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.7 | 37.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.7 | 3.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 3.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.7 | 1.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 38.1 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 61.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 3.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 16.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 6.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.7 | 6.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 5.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 8.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 2.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 28.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 4.0 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 3.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.7 | 7.2 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.7 | 20.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 10.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.6 | 5.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 1.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.6 | 1.9 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 2.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 8.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.6 | 3.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 5.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 1.8 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 1.8 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 28.6 | GO:0005657 | replication fork(GO:0005657) |
0.6 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 3.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 52.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.6 | 1.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 3.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 2.4 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 2.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 1.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 6.5 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 6.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 31.5 | GO:0016605 | PML body(GO:0016605) |
0.6 | 3.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.6 | 10.4 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 3.5 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 8.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.6 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 3.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.6 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 10.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 1.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 3.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 3.8 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 1.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 34.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 11.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 2.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 1.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.5 | 2.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 15.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 4.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 8.7 | GO:0015030 | Cajal body(GO:0015030) |
0.5 | 2.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 3.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 1.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.5 | 7.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 7.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.5 | 1.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 3.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.5 | 3.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 11.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.5 | 71.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 1.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.5 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 5.8 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.5 | 33.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 3.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.5 | 1.9 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 1.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 1.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 2.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 8.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 2.7 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 5.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 6.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 3.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 26.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 19.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 1.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 2.7 | GO:0031430 | M band(GO:0031430) |
0.4 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 1.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 6.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 7.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 17.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 2.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 45.1 | GO:0005903 | brush border(GO:0005903) |
0.4 | 16.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 5.6 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 16.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 3.4 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.4 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 2.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 13.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 22.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 3.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 10.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 6.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 5.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.4 | 3.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 4.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 9.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 4.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 5.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 142.7 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.4 | 421.2 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 7.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 5.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 6.2 | GO:0043034 | costamere(GO:0043034) |
0.4 | 2.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 6.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 1.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 3.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 7.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 3.2 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 2.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 2.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 2.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 3.1 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 5.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 1.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 7.7 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.7 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 11.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 4.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 0.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 2.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 2.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 2.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 33.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.3 | 2.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 2.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 3.5 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 253.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 147.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 1.0 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 3.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 5.0 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.4 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 4.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 9.9 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 4.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 1.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.2 | 0.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 2.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 8.8 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 2.6 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 4.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 16.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 3.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 25.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 3.3 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 21.7 | GO:0031967 | organelle envelope(GO:0031967) envelope(GO:0031975) |
0.2 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 2.2 | GO:0098562 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
0.2 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 3.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 203.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 3.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.7 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 4.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 14.1 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 6.1 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 3.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 4.2 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 10.0 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 4.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 71.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 11.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 15.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.1 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 2.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 19.6 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 6.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 2.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 62.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 7.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
6.1 | 18.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
5.0 | 15.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
4.3 | 17.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.1 | 12.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.0 | 12.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.8 | 11.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.7 | 25.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.5 | 10.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.5 | 20.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
3.3 | 9.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.0 | 9.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
2.8 | 5.7 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
2.7 | 10.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.7 | 5.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.7 | 10.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.6 | 7.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.6 | 10.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
2.6 | 10.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.6 | 2.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.6 | 2.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
2.6 | 7.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.5 | 7.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.5 | 44.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.5 | 7.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.4 | 7.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.4 | 9.7 | GO:0043515 | kinetochore binding(GO:0043515) |
2.4 | 11.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.4 | 19.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.3 | 9.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 13.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.2 | 9.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.2 | 6.5 | GO:0070905 | serine binding(GO:0070905) |
2.1 | 8.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.9 | 1.9 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.9 | 5.8 | GO:0019961 | interferon binding(GO:0019961) |
1.9 | 5.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.9 | 5.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.9 | 5.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 5.5 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.8 | 7.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.8 | 7.3 | GO:0030984 | kininogen binding(GO:0030984) |
1.8 | 10.7 | GO:0008199 | ferric iron binding(GO:0008199) |
1.8 | 8.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.8 | 7.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.7 | 6.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.7 | 5.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.7 | 8.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.7 | 8.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.7 | 1.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.7 | 20.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.6 | 4.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.6 | 3.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.6 | 6.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.6 | 4.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.6 | 19.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.6 | 1.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
1.6 | 4.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.6 | 14.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.6 | 4.7 | GO:0070840 | dynein complex binding(GO:0070840) |
1.5 | 3.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
1.5 | 6.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.5 | 4.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.5 | 6.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.5 | 10.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.5 | 7.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.5 | 13.1 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.4 | 8.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 4.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 4.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 4.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.4 | 7.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.4 | 1.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.4 | 4.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.4 | 1.4 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
1.4 | 23.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.4 | 15.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.4 | 6.8 | GO:0008430 | selenium binding(GO:0008430) |
1.3 | 6.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.3 | 2.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.3 | 5.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.3 | 4.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.3 | 5.2 | GO:0035671 | enone reductase activity(GO:0035671) |
1.3 | 5.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 3.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.3 | 10.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.3 | 3.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.3 | 15.6 | GO:0019825 | oxygen binding(GO:0019825) |
1.3 | 29.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.3 | 9.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.3 | 9.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.3 | 5.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.3 | 6.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.3 | 3.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.3 | 5.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.3 | 1.3 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.2 | 5.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.2 | 3.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 3.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.2 | 9.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 1.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.2 | 3.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.2 | 13.4 | GO:0016208 | AMP binding(GO:0016208) |
1.2 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.2 | 2.4 | GO:0070538 | oleic acid binding(GO:0070538) |
1.2 | 3.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.2 | 3.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.2 | 3.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.2 | 1.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.2 | 1.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.1 | 5.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.1 | 5.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.1 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 3.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.1 | 1.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
1.1 | 5.6 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 6.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.1 | 3.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.1 | 5.5 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.1 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 3.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 5.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.1 | 2.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.1 | 3.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 4.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.0 | 3.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.0 | 3.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.0 | 15.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.0 | 3.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 6.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.0 | 3.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 3.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.0 | 6.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 19.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 4.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.0 | 9.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 5.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.0 | 3.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.0 | 1.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.0 | 4.0 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 4.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 5.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.0 | 3.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
1.0 | 21.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.0 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 7.8 | GO:0010181 | FMN binding(GO:0010181) |
1.0 | 4.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 4.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.0 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 3.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.0 | 28.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.9 | 3.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 4.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 2.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.9 | 3.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 5.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.9 | 2.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 6.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 2.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 6.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.9 | 4.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 2.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.9 | 4.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 4.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 3.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.9 | 6.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.9 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.9 | 2.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 1.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 2.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 3.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 2.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 3.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.9 | 7.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 5.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 7.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.9 | 2.6 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 7.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.9 | 11.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 8.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 9.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.8 | 10.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.8 | 2.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.8 | 5.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.8 | 2.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.8 | 2.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 6.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 1.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.8 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.8 | 3.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.8 | 3.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.8 | 2.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 2.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 11.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.8 | 2.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.8 | 2.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 2.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 2.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 13.7 | GO:0001848 | complement binding(GO:0001848) |
0.8 | 3.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 5.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.8 | 3.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 5.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 0.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.8 | 0.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.8 | 10.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 26.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.8 | 7.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 8.6 | GO:0015250 | water channel activity(GO:0015250) |
0.8 | 2.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 1.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.8 | 3.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 4.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 3.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.8 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.8 | 5.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.8 | 2.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 8.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 3.0 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.8 | 3.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 21.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 3.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 3.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 3.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 8.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.7 | 7.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.7 | 11.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.7 | 10.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 5.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 4.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.7 | 15.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 11.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 15.7 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 5.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 9.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 2.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 5.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 4.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.7 | 10.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 2.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.7 | 7.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 2.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 13.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 10.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 20.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 18.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 13.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.7 | 3.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 4.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 38.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 2.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 2.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.7 | 1.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.7 | 17.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 2.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 0.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.7 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 5.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.7 | 2.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 11.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 2.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 2.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 7.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.7 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 2.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 2.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.7 | 10.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 4.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 8.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 5.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 28.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.6 | 0.6 | GO:0030523 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.6 | 3.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 9.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 1.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.6 | 1.9 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.3 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.6 | 3.8 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 1.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.6 | 0.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.6 | 1.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 1.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 1.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 8.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 11.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.6 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.6 | 4.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.6 | 1.8 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.6 | 7.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.6 | 3.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 15.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 5.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 2.4 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 1.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 2.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.6 | 3.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.6 | 2.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 1.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 7.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 46.8 | GO:0002020 | protease binding(GO:0002020) |
0.6 | 2.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 1.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 2.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.6 | 5.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 11.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.6 | 2.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.6 | 2.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.6 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 6.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.6 | 17.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 16.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.6 | 2.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.6 | 2.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 2.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 3.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 3.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 3.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.6 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.6 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 12.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 5.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.5 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 4.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 15.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 5.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 10.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.5 | 3.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 9.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 11.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 4.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 27.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.5 | 2.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.5 | 8.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 3.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 2.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 5.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 3.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 6.2 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.5 | 15.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.5 | 15.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.5 | 15.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.5 | 3.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.5 | 2.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 0.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.5 | 1.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.5 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 2.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 11.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 4.9 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 1.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 42.4 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.5 | 11.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 3.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.5 | 3.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.5 | 5.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.5 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 1.9 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.5 | 9.5 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.5 | 1.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 4.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.5 | 4.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 3.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 1.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 0.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 2.8 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.5 | 1.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.5 | 2.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.5 | 1.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 15.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.5 | 3.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 6.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.5 | 4.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.8 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 2.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 7.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 16.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 6.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 19.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 8.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 3.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 2.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 5.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 2.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 5.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 4.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 17.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 2.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 4.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 3.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 11.0 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 16.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 16.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.4 | 10.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 3.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 2.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 1.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 3.9 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
0.4 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) S-succinyltransferase activity(GO:0016751) |
0.4 | 4.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.4 | 6.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 18.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 3.0 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 2.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 2.3 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 3.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 11.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 0.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 2.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 0.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.4 | 2.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.4 | 11.6 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 11.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.4 | 1.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 4.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 3.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 5.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 9.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 1.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.4 | 25.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 2.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.4 | 1.1 | GO:0018471 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.4 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 3.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 12.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 1.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 3.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 4.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 1.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 34.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 1.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 5.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 5.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 1.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 5.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.3 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.3 | 1.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 1.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 1.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 6.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 1.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 7.3 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.9 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.3 | 38.5 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.3 | 1.8 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.3 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 6.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 3.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 0.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.3 | 12.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 2.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 5.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.0 | GO:0090484 | drug transporter activity(GO:0090484) |
0.3 | 0.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 3.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 2.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 1.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 3.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 2.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.3 | 0.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 14.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 19.2 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 0.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 14.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 3.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 7.1 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 2.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 5.1 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 5.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 1.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.3 | GO:0070568 | mannose-phosphate guanylyltransferase activity(GO:0008905) guanylyltransferase activity(GO:0070568) |
0.3 | 12.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 42.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 6.7 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.2 | 41.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 4.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 3.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 3.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 17.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 2.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 7.7 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 1.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 17.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.2 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) sugar transmembrane transporter activity(GO:0051119) carbohydrate transporter activity(GO:1901476) |
0.2 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 5.9 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 4.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 3.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 2.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 18.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 4.7 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 14.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 2.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 8.5 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 3.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.4 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 4.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 1.6 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 8.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 2.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 6.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 84.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 28.6 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 5.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.5 | GO:0047617 | palmitoyl-CoA hydrolase activity(GO:0016290) acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 3.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 1.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 17.1 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 2.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 7.5 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 3.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 6.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 11.6 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 3.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 3.6 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.2 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 7.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.7 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 5.0 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.5 | GO:0016853 | isomerase activity(GO:0016853) |
0.1 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 2.1 | GO:0005253 | anion channel activity(GO:0005253) |
0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 3.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 39.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 5.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 3.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 1.4 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.9 | 65.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.5 | 7.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.3 | 10.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.3 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 18.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 11.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.1 | 18.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.0 | 11.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 3.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 9.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.0 | 29.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 8.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 24.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 12.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 40.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 24.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.9 | 13.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 33.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 22.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 26.5 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 28.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 6.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.8 | 10.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 21.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 5.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 33.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 15.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.7 | 2.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.7 | 2.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 9.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 4.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.7 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 3.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 10.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 6.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 24.0 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 5.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 7.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 12.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.6 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 4.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 5.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 29.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 8.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 8.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 6.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 8.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 12.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 10.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 3.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 15.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 5.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 2.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 9.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 3.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 8.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 6.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 9.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 4.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 12.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 8.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 12.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 19.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 4.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 15.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 8.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 2.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 8.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 7.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 3.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 2.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 2.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 2.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 2.6 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 9.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 19.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 2.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 1.5 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 5.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 7.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 3.4 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 5.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 3.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 3.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 2.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 6.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 4.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 4.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 3.2 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 30.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 33.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.8 | 13.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.4 | 21.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.2 | 22.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.2 | 21.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.1 | 38.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.0 | 14.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.0 | 28.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.9 | 22.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.8 | 49.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.6 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.5 | 17.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.5 | 8.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.4 | 12.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.4 | 12.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.4 | 15.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.3 | 16.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.3 | 13.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 14.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.3 | 17.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
1.3 | 12.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 11.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 9.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 32.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 14.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.1 | 11.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.1 | 7.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.1 | 10.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.1 | 28.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.0 | 13.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.0 | 26.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.0 | 3.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.0 | 15.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 22.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.0 | 27.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.0 | 16.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 28.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 5.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 15.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.0 | 11.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.0 | 1.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 2.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 28.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 3.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.9 | 5.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.8 | 7.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 15.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 1.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.8 | 8.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 10.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.8 | 13.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.8 | 1.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.8 | 1.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 10.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.8 | 8.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 1.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 8.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 0.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.7 | 11.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.7 | 20.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.7 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 19.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 1.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.7 | 31.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.7 | 10.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.7 | 43.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 7.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 11.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.7 | 10.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.7 | 41.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.7 | 18.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.7 | 6.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 9.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.7 | 3.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 10.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 5.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 12.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.7 | 7.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 42.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 8.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 5.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.6 | 9.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.6 | 3.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 28.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 8.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.6 | 4.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 8.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 10.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 4.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 5.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 41.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 12.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 7.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 5.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 9.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 5.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 13.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 5.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 3.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.5 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.5 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 10.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 7.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 10.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 3.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 4.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 2.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 4.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 67.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 3.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 4.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 2.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 14.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 2.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 10.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 2.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.4 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 5.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 0.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.4 | 1.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 3.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.4 | 6.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 14.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 2.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 3.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 7.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 5.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 3.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 8.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 8.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 5.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 11.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 2.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.4 | 3.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 7.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 10.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 6.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 7.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 1.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 3.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 2.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 19.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 3.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 0.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 3.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 35.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 3.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 3.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 26.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 7.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 9.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 4.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 4.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 8.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 6.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 1.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 6.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 6.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 8.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 12.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 5.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 8.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 1.6 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 2.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.1 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 2.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |